RT Journal Article
SR Electronic
T1 Estimating internationally imported cases during the early COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.23.20038331
DO 10.1101/2020.03.23.20038331
A1 Tigist F. Menkir
A1 Taylor Chin
A1 James Hay
A1 Erik D. Surface
A1 Pablo M. De Salazar
A1 Caroline O. Buckee
A1 Alexander Watts
A1 Kamran Khan
A1 Ryan Sherbo
A1 Ada W. C. Yan
A1 Michael Mina
A1 Marc Lipsitch
A1 Rene Niehus
YR 2020
UL http://medrxiv.org/content/early/2020/07/17/2020.03.23.20038331.abstract
AB Early in the COVID-19 pandemic, when cases were predominantly reported in the city of Wuhan, China, local outbreaks in Europe, North America, and Asia were largely predicted from imported cases on flights from Wuhan, potentially missing imports from other key source cities. Here, we account for importations from Wuhan and from other cities in China, combining COVID-19 prevalence estimates in 18 Chinese cities with estimates of flight passenger volume to predict for each day between early December 2019 to late February 2020 the number of cases exported from China. We predict that the main source of global case importation in early January was Wuhan, but due to the Wuhan lockdown and the rapid spread of the virus, the main source of case importation from mid February became Chinese cities outside of Wuhan. For destinations in Africa in particular, non-Wuhan cities were an important source of case imports (1 case from those cities for each case from Wuhan, range of model scenarios: 0.1-9.8). Our model predicts that 18.4 (8.5 - 100) COVID-19 cases were imported to 26 destination countries in Africa, with most of them (90%) predicted to have arrived between 7th January (±10 days) and 5th February (±3 days), and all of them predicted prior to the first case detections. We finally observed marked heterogeneities in expected imported cases across those locations. Our estimates shed light on shifting sources and local risks of case importation which can help focus surveillance efforts and guide public health policy during the final stages of the pandemic. We further provide a time window for the seeding of local epidemics in African locations, a key parameter for estimating expected outbreak size and burden on local health care systems and societies, that has yet to be defined in these locations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementML, TFM, TC and RN were supported by Award Number U54GM088558 from the US National Institute Of General Medical Sciences. PMD was supported by the Fellowship Foundation Ramon Areces. COB was supported by a NIGMS Maximizing Investigators Research Award (MIRA) R35GM124715-02.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTransformed flight data, derived prevalence data, and all code used in these analyses to be made fully available online at https://github.com/c2-d2/COVID_allchina_export